Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma

Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been triall...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Fiona A, Katona, Lynda, Jefford, Michael, Smith, Allan Ben, Shaw, Joanne, Dhillon, Haryana M, Ellen, Steve, Phipps-Nelson, Jo, Lai-Kwon, Julia, Milne, Donna, Russell, Lahiru, Dax, Victoria, Diggens, Justine, Kent, Holly, Button-Sloan, Alison, Elliott, Jane, Shackleton, Mark, Burridge, Hayley, Ftanou, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565154/
https://www.ncbi.nlm.nih.gov/pubmed/32937942
http://dx.doi.org/10.3390/jcm9092969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565154/
https://www.ncbi.nlm.nih.gov/pubmed/32937942
http://dx.doi.org/10.3390/jcm9092969

Ejemplares similares